Extracorporeal membrane oxygenation (ECMO) is a special procedure that uses an artificial heart-lung machine to take over the work of the lungs (and sometimes also the heart).
Refractory hypoxemia is a severe form of low oxygen levels in the blood that does not respond well to standard oxygen therapy. It can be challenging to manage and may require advanced interventions such as mechanical ventilation or extracorporeal membrane oxygenation (ECMO) to improve oxygenation.
Intrapulmonary shunting occurs when blood bypasses alveoli, leading to inadequate oxygenation. Management typically involves treating the underlying cause, such as addressing pneumonia, pulmonary edema, or atelectasis. Supportive measures may include supplemental oxygen therapy and mechanical ventilation to improve gas exchange. In severe cases, advanced interventions like extracorporeal membrane oxygenation (ECMO) may be considered.
Extracorporeal Life Support Organization was created in 1989.
An extracorporeal circuit
Extracorporeal shock wave lithotripsy
The duration a patient can remain on an ECMO (Extracorporeal Membrane Oxygenation) machine varies, typically ranging from a few days to several weeks, depending on the patient's condition and response to treatment. Prolonged use beyond two weeks may increase the risk of complications, such as bleeding, infection, or organ dysfunction. Ultimately, the decision is made by the medical team based on the patient's specific situation and prognosis. Regular assessments are essential to determine the appropriateness of continued ECMO support.
Hemoperfusion is sometimes described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body.
extracorporeal removal of drug is a system in which undesirable drug and metabolites from the body without disturbing the fluid and electrolytr balance in the patient. answred by saikat
extracorporeal
perfusionist
Extracorporeal
the procedure is termed extracorporeal shock wave lithotripsy (ESWL).